1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

10 Nov 2020
Admin
News Article

Vifor Pharma And Angion Sign License Agreement For Ang-3777 In Nephrology Indications

Vifor Pharma And Angion Biomedica Corp. (Angion) Announced The Signing Of A Licensing Agreement For The Commercialization Of Ang-3777, Currently Developed For Treatment Of Delayed Graft Function (Dgf) And Cardiac Surgery-Associated Acute Kidney Injury (Csa-Aki). Ang-3777 Was Engineered To Mimic The Biological Activity Of Hgf, Activating Critical Pathways In The Body&Rsquo;S Natural Organ Repair Process Following An Acute Organ Injury.Under The Terms Of The Agreement, Vifor Pharma Will Receive An Exclusive Global License, Excluding China, Taiwan, Hong Kong And Macau, For All Ang-3777 Nephrology Indications. Angion Will Receive Up To Usd 80 Million Which Includes A 30 Million Upfront Payment, A 30 Million Equity Investment And 20 Million In Clinical Study Milestone Payments. Additionally Angion Is Eligible To Receive Up To Usd 260 Million In Market Access Related Milestones Upon Approval In Us And Eu, Further Payments In The Form Of Sales Milestones, And Tiered Royalties On Global Net Sales Up To 40% At The High End Of The Royalty Range.&Ldquo;This Agreement Highlights The Leadership Position That Vifor Pharma Has Developed In The Nephrology Space And The Fact That It Has Become The Company Of Choice For Organizations Committed To Partnering Innovative Nephrology Focused Assets&Ldquo; Said Stefan Schulze, Chief Executive Officer Of Vifor Pharma. &Ldquo;Angion Is An Excellent Partner With An Outstanding Expertise Leading To The Development Of This Exciting Asset And Other Pipeline Products. We Look Forward To Working Closely With Angion Who Will Be Responsible For The Ongoing Development Program Of Ang-3777 And To Leveraging Our Commercial Expertise To Bring This Highly Promising, Innovative Treatment With A Unique Mode Of Action To Patients Suffering From Dgf And Csa-Aki. These Are Both Critical Conditions, Currently Without Any Effective Or Approved Therapies.&Rdquo;&Ldquo;Vifor Pharma Is One Of The World Leaders In The Nephrology Space And We Are Very Excited To Partner With Them On The Commercialization Of Ang

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!